$-0.14 EPS Expected for Tilray, Inc. (TLRY)

November 10, 2018 - By Adrian Erickson

Analysts expect Tilray, Inc. (NASDAQ:TLRY) to report $-0.14 EPS on November, 27.After having $-0.17 EPS previously, Tilray, Inc.’s analysts see -17.65 % EPS growth. The stock decreased 8.18% or $9.71 during the last trading session, reaching $108.99. About 3.00 million shares traded. Tilray, Inc. (NASDAQ:TLRY) has 0.00% since November 11, 2017 and is . It has underperformed by 15.62% the S&P500.

Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company has market cap of $10.15 billion. The firm offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. It currently has negative earnings.

More notable recent Tilray, Inc. (NASDAQ:TLRY) news were published by: Seekingalpha.com which released: “Stocks To Watch: All Eyes On Walmart, Volkswagen And A Jedi Contract” on November 10, 2018, also Fool.com with their article: “Why Tilray Crushed It Today” published on November 07, 2018, Fool.com published: “Better Marijuana Stock: Tilray vs. CannTrust Holdings” on October 28, 2018. More interesting news about Tilray, Inc. (NASDAQ:TLRY) were released by: Fool.com and their article: “Why Canopy Growth Corporation, Cronos Group, and Tilray Are Sinking Again Today” published on October 29, 2018 as well as Benzinga.com‘s news article titled: “2 Cannabis Stocks Becoming Popular Short-Seller Targets” with publication date: October 23, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: